Brief: Stereotaxis receives FDA clearance of Vdrive with v-Cas system
Jan 5 (Reuters) - Stereotaxis Inc STXS.O : * Receives FDA clearance of Vdrive(R) with v-Cas(TM) system along with regulatory approval of Odyssey(R) system in Japan * Says received regulatory approval of its odyssey product line by Japan pharmaceuticals and medical devices agency * Says expects to submit its vdrive system for regulatory review in Japan during the first quarter of 2015 * Source text for Eikon ID:nGNXVCKEXa * Further company coverage STXS.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Stereotaxis
See all newsStereotaxis Q2 revenue misses estimates, dragged by system decline
Brief: Stereotaxis Q2 Revenue USD 7.67 Million Vs. IBES Estimate USD 8.35 Million
Surgical robotics provider Stereotaxis' Q1 revenue misses analyst estimates
Stereotaxis rises after FDA clears new heart-procedure platform
Surgical robotics firm Stereotaxis Q4 revenue jumps